UMIN-ICDS Clinical Trial
| Unique ID issued by UMIN | UMIN000063465 |
|---|---|
| Receipt number | R000069041 |
| Scientific Title | Development and Evaluation of a Web-Based Education System to Promote Cervical Cancer Screening |
| Date of disclosure of the study information | 2026/11/01 |
| Last modified on | 2026/10/29 17:39:38 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Verification of the Effectiveness of a Web-Based Educational System to Promote Cervical Cancer Screening: A Randomized Controlled Trial
Acronym
Verification of the Effectiveness of a Web-Based Educational System to Promote Cervical Cancer Screening: A Randomized Controlled Trial
Scientific Title
Development and Evaluation of a Web-Based Education System to Promote Cervical Cancer Screening
Scientific Title:Acronym
WBE-ECCS Trial
Region
| Japan |
Condition
Condition
Cervical Cancer
Classification by specialty
| Obstetrics and Gynecology | Nursing |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
The objective of this study was to determine whether providing a URL to a web-based platform featuring a cervical cancer screening promotion video and functions for searching screening information and supporting appointment booking would increase cervical cancer screening uptake compared with an email-only control condition.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Explanatory
Developmental phase
Phase I
Assessment
Primary outcomes
Cervical cancer screening participation status, screening rate
Key secondary outcomes
Changes in the 7 stages of health behavior related to cervical cancer screening Precaution Adoption Process Model
Number of correct answers regarding cervical cancer screening knowledge
(Before intervention, 1 month after intervention, 3 months after intervention
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
No treatment
Stratification
YES
Dynamic allocation
NO
Institution consideration
Institution is considered as a block.
Blocking
YES
Concealment
No need to know
Intervention
No. of arms
2
Purpose of intervention
Prevention
Type of intervention
| Other |
Interventions/Control_1
Providing video materials on the causes of cervical cancer, infection rates, turning points, and how to receive municipal cervical cancer screenings
Interventions/Control_2
Providing a search system for the timing and appointment methods of cervical cancer screenings offered by the municipality where participants are registered, as well as a search system for the addresses and appointment methods of medical institutions conducting cervical cancer screenings.
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 40 | years-old | > |
Gender
Female
Key inclusion criteria
(1) Registered residence in Tokyo, Chiba Prefecture, or the Kanto region
(2) Individuals who have not already undergone cervical cancer screening in the current fiscal year
(3) Individuals who own and can use a personal computer, smartphone, tablet, or similar device
Key exclusion criteria
Individuals aged 40 or older residing outside Tokyo, Chiba Prefecture, or the Kanto region.
Individuals with no history of sexual contact.
Individuals not within the screening age range for their municipality of residence in the current fiscal year.
Individuals who have already undergone cervical cancer screening in the current fiscal year,
Individuals with a history of cervical cancer within the past 3 years, Individuals with a history of hysterectomy,
Individuals currently undergoing outpatient treatment for gynecological diseases, Pregnant individuals
Target sample size
500
Research contact person
Name of lead principal investigator
| 1st name | Sachiko |
| Middle name | |
| Last name | Iijima |
Organization
Juntendo University
Division name
Graduate Schoolof Healthcare andNursing
Zip code
2790023
Address
2-5-1 Takasu, Urayasu-shi, Chiba
TEL
0473504026
siijima@juntendo.ac.jp
Public contact
Name of contact person
| 1st name | Sachiko |
| Middle name | |
| Last name | Iijima |
Organization
Juntendo University
Division name
Graduate Schoolof Healthcare andNursing
Zip code
279-0023
Address
2-5-1 Takasu, Urayasu-shi, Chiba
TEL
047-350-4026
Homepage URL
siijima@juntendo.ac.jp
Sponsor or person
Institute
Juntendo University
Institute
Department
Personal name
Sachiko Iijima
Funding Source
Organization
Ministry of Education, Culture, Sports, Science and Technology
Organization
Division
Category of Funding Organization
Government offices of other countries
Nationality of Funding Organization
japan
Other related organizations
Co-sponsor
None
Name of secondary funder(s)
None
IRB Contact (For public release)
Organization
Juntendo University Faculty of Nursing and Medical Sciences Ethics Review Committee
Address
2-5-1 Takasu, Urayasu-shi, Chiba
Tel
047-355-3111
mtakaya@juntendo.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2026 | Year | 11 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Partially published
Result
URL related to results and publications
Number of participants that the trial has enrolled
337
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
No longer recruiting
Date of protocol fixation
| 2025 | Year | 09 | Month | 10 | Day |
Date of IRB
| 2025 | Year | 09 | Month | 29 | Day |
Anticipated trial start date
| 2026 | Year | 01 | Month | 19 | Day |
Last follow-up date
| 2026 | Year | 05 | Month | 27 | Day |
Date of closure to data entry
| 2026 | Year | 05 | Month | 30 | Day |
Date trial data considered complete
| 2026 | Year | 05 | Month | 30 | Day |
Date analysis concluded
| 2026 | Year | 12 | Month | 25 | Day |
Other
Other related information
Management information
Registered date
| 2026 | Year | 10 | Month | 29 | Day |
Last modified on
| 2026 | Year | 10 | Month | 29 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069041
